Efficacy of inhaled prostanoids in pulmonary hypertension

被引:0
|
作者
Kleen, M
Habler, O
Hofstetter, C
Pusch, R
Muller, M
Welte, M
Zwissler, B
机构
[1] UNIV MUNICH,INST ANESTHESIOL,D-81366 MUNICH,GERMANY
[2] UNIV MUNICH,INST SURG RES,D-81366 MUNICH,GERMANY
[3] UNIV TUBINGEN,DEPT ANESTHESIOL,D-72076 TUBINGEN,GERMANY
关键词
D O I
10.1097/00000542-199709001-00515
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:A515 / A515
页数:1
相关论文
共 50 条
  • [1] Efficacy of inhaled prostanoids in experimental pulmonary hypertension
    Kleen, M
    Habler, O
    Hofstetter, C
    Pusch, R
    Mueller, M
    Welte, M
    Zwissler, B
    CRITICAL CARE MEDICINE, 1998, 26 (06) : 1103 - 1109
  • [2] Inhaled prostanoids in the therapy of pulmonary hypertension
    Gessler, Tobias
    Seeger, Werner
    Schmehl, Thomas
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2008, 21 (01) : 1 - 12
  • [3] Safety and Efficacy of Transition from Systemic Prostanoids to Inhaled Treprostinil in Pulmonary Arterial Hypertension
    Perez, Vinicio A. de Jesus
    Rosenzweig, Erica
    Rubin, Lewis J.
    Poch, David
    Bajwa, Abubakr
    Park, Myung
    Jain, Mohit
    Bourge, Robert C.
    Kudelko, Kristina
    Spiekerkoetter, Edda
    Liu, Juliana
    Hsi, Andrew
    Zamanian, Roham T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (10): : 1546 - 1550
  • [4] Efficacy of inhaled prostanoids in experimental pulmonary hypertension (vol 26, pg 1103, 1998)
    Kleen, M
    Habler, O
    Hofstetter, C
    Pusch, R
    Mueller, M
    CRITICAL CARE MEDICINE, 1998, 26 (07) : 1294 - 1294
  • [5] Transitioning from IV/SQ prostanoids to inhaled iloprost in patients with pulmonary arterial hypertension
    Saggar, Rajeev
    Sulica, Roxana
    Williamson, Timothy
    Kim, Nick H.
    Channick, Richard N.
    CHEST, 2006, 130 (04) : 257S - 258S
  • [6] Different efficacy of inhaled and oral medications in pulmonary hypertension
    AbuHalimeh, Batool J.
    Parambil, Joseph G.
    Tonelli, Adriano R.
    HEART & LUNG, 2017, 46 (04): : 334 - 337
  • [7] Prostanoids in the treatment of pulmonary arterial hypertension
    Baskurt, Murat
    Kucukoglu, M. Serdar
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 : 2 - 8
  • [8] An advanced protocol-driven transition from parenteral prostanoids to inhaled trepostinil in pulmonary arterial hypertension
    Oudiz, Ronald
    Agarwal, Manyoo
    Rischard, Franz
    De Marco, Teresa
    Pulmonary Circulation, 2016, 6 (04) : 532 - 538
  • [9] Transition from parenteral prostanoids to inhaled iloprost for, treatment of severe pulmonary arterial hypertension: Midterm outcomes
    Studer, Sean M.
    Zhang, Joan
    MacNamara, Dennis
    Alvarez, Rene
    Mathier, Michael A.
    CHEST, 2007, 132 (04) : 635S - 635S
  • [10] PROSTANOIDS IN NEONATES WITH PERSISTENT PULMONARY-HYPERTENSION
    HAMMERMAN, C
    LASS, N
    STRATES, E
    KOMAR, K
    BUI, KC
    JOURNAL OF PEDIATRICS, 1987, 110 (03): : 470 - 472